EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
Clinical trial NCT01000285 · COMPLETED
Trial details
- NCT number
- NCT01000285
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2014-05-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.